Healthcare provider profile · identity verified

Jeffrey Patrick Mcguire, MD

Family Practice · FORT ATKINSON, WI · NPI 1588624654

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	734	199
Losartan Potassium	Losartan Potassium	505	128
Amlodipine Besylate	Amlodipine Besylate	479	124
Omeprazole	Omeprazole	472	121
Levothyroxine Sodium	Levothyroxine Sodium	391	85
Metoprolol Succinate	Metoprolol Succinate	346	91
Lisinopril	Lisinopril	317	82
Pantoprazole Sodium	Pantoprazole Sodium	274	66
Gabapentin	Gabapentin	271	60
Eliquis	Apixaban	246	48
Hydrochlorothiazide	Hydrochlorothiazide	240	71
Furosemide	Furosemide	236	65
Rosuvastatin Calcium	Rosuvastatin Calcium	229	59
Tamsulosin Hcl	Tamsulosin Hcl	207	63
Ezetimibe	Ezetimibe	191	48
Famotidine	Famotidine	182	38
Metformin Hcl	Metformin Hcl	174	50
Metoprolol Tartrate	Metoprolol Tartrate	174	46
Carvedilol	Carvedilol	168	42
Metformin Hcl Er	Metformin Hcl	126	33
Allopurinol	Allopurinol	123	33
Venlafaxine Hcl Er	Venlafaxine Hcl	122	25
Pravastatin Sodium	Pravastatin Sodium	121	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	29
Sertraline Hcl	Sertraline Hcl	116	27
Celecoxib	Celecoxib	114	33
Fluticasone Propionate	Fluticasone Propionate	113	40
Fenofibrate	Fenofibrate,micronized	109	26
Atenolol	Atenolol	108	22
Simvastatin	Simvastatin	100	25
Clopidogrel	Clopidogrel Bisulfate	99	27
Albuterol Sulfate Hfa	Albuterol Sulfate	95	33
Tramadol Hcl	Tramadol Hcl	92	24
Escitalopram Oxalate	Escitalopram Oxalate	91	22
Mounjaro	Tirzepatide	91	21
Trazodone Hcl	Trazodone Hcl	89	24
Donepezil Hcl	Donepezil Hcl	84	20
Lorazepam	Lorazepam	82	27
Potassium Chloride	Potassium Chloride	81	21
Citalopram Hbr	Citalopram Hydrobromide	78	16
Spironolactone	Spironolactone	78	18
Baclofen	Baclofen	69	12
Sucralfate	Sucralfate	69	14
Duloxetine Hcl	Duloxetine Hcl	62	13
Finasteride	Finasteride	62	16
Tizanidine Hcl	Tizanidine Hcl	62	26
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Azithromycin	Azithromycin	55	33
Ibuprofen	Ibuprofen	55	20
Clonazepam	Clonazepam	54	12
Fluoxetine Hcl	Fluoxetine Hcl	54	12
Glipizide Er	Glipizide	53	11
Trulicity	Dulaglutide	52	suppressed
Nabumetone	Nabumetone	50	21
Amoxicillin	Amoxicillin	49	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	16
Mirtazapine	Mirtazapine	48	suppressed
Pregabalin	Pregabalin	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	12
Glimepiride	Glimepiride	44	14
Nifedipine Er	Nifedipine	44	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	11
Oxycodone Hcl	Oxycodone Hcl	42	11
Fenofibrate	Fenofibrate	40	11
Montelukast Sodium	Montelukast Sodium	40	suppressed
Alprazolam	Alprazolam	39	11
Irbesartan	Irbesartan	39	12
Oxybutynin Chloride Er	Oxybutynin Chloride	39	11
Bupropion Hcl Sr	Bupropion Hcl	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Valsartan	Valsartan	37	12
Folic Acid	Folic Acid	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	21
Nitroglycerin	Nitroglycerin	28	17
Bumetanide	Bumetanide	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	18
Buspirone Hcl	Buspirone Hcl	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Xarelto	Rivaroxaban	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Ozempic	Semaglutide	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Rybelsus	Semaglutide	23	suppressed
Colchicine	Colchicine	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Glipizide	Glipizide	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Prednisone	Prednisone	21	suppressed
Rivastigmine	Rivastigmine Tartrate	21	suppressed
Cephalexin	Cephalexin	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Meloxicam	Meloxicam	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	17	12
Carbamazepine Er	Carbamazepine	17	suppressed
Naproxen	Naproxen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Estradiol	Estradiol	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Cholestyramine Light	Cholestyramine	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Mesalamine Er	Mesalamine	14	suppressed
Testosterone	Testosterone	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Cevimeline Hcl	Cevimeline Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Farxiga	Dapagliflozin Propanediol	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Nystatin	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error